These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 21323689

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Drug resistance in inflammatory bowel diseases.
    Moreau J, Mas E.
    Curr Opin Pharmacol; 2015 Dec; 25():56-61. PubMed ID: 26645664
    [Abstract] [Full Text] [Related]

  • 4. General principles of medical therapy of inflammatory bowel disease.
    Friedman S.
    Gastroenterol Clin North Am; 2004 Jun; 33(2):191-208, viii. PubMed ID: 15177534
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of chronic inflammatory bowel diseases].
    Lémann M.
    Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Benefits and risks of immunosuppression in chronic inflammatory bowel diseases].
    Rogler G.
    Dtsch Med Wochenschr; 2008 Sep; 133(38):1917-21. PubMed ID: 18785084
    [No Abstract] [Full Text] [Related]

  • 8. Biological therapies in inflammatory bowel disease: top-down or bottom-up?
    Oldenburg B, Hommes D.
    Curr Opin Gastroenterol; 2007 Jul; 23(4):395-9. PubMed ID: 17545775
    [Abstract] [Full Text] [Related]

  • 9. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Biological therapies of inflammatory bowel disease.
    Bai A, Peng Z.
    Immunotherapy; 2010 Sep; 2(5):727-42. PubMed ID: 20874655
    [Abstract] [Full Text] [Related]

  • 13. Inflammatory bowel disease.
    Podolsky DK.
    N Engl J Med; 2002 Aug 08; 347(6):417-29. PubMed ID: 12167685
    [No Abstract] [Full Text] [Related]

  • 14. Therapeutic approaches in inflammatory bowel disease based on the immunopathogenesis.
    Siegmund B, Zeitz M.
    Rocz Akad Med Bialymst; 2004 Aug 08; 49():22-30. PubMed ID: 15631310
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Crohn's disease: current treatment options.
    Akobeng AK.
    Arch Dis Child; 2008 Sep 08; 93(9):787-92. PubMed ID: 18456695
    [Abstract] [Full Text] [Related]

  • 17. [Treatment strategies for inflammatory bowel disease].
    Lémann M, Allez M.
    Rev Prat; 2005 May 15; 55(9):984-92. PubMed ID: 16052969
    [Abstract] [Full Text] [Related]

  • 18. [Drug therapy and nutrition therapy of a young patient with Crohn disease].
    Verkasalo M.
    Duodecim; 2003 May 15; 119(7):617-24. PubMed ID: 12762201
    [No Abstract] [Full Text] [Related]

  • 19. American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.
    Lichtenstein GR, Abreu MT, Cohen R, Tremaine W, American Gastroenterological Association.
    Gastroenterology; 2006 Mar 15; 130(3):935-9. PubMed ID: 16530531
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacogenetics of inflammatory bowel disease.
    Katsanos KH, Papadakis KA.
    Pharmacogenomics; 2014 Dec 15; 15(16):2049-62. PubMed ID: 25521361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.